CollPlant Biotechnologies Ltd (CLGN) Implied Volatility Current

Tracking CLGN implied volatility helps you identify when options premiums on CollPlant Biotechnologies Ltd are historically cheap or expensive, and where the best trades are hiding. CollPlant Biotechnologies Ltd implied volatility reflects the market's expectation of future price movement: when CLGN IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor CollPlant Biotechnologies Ltd's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For CLGN, tracking metrics like CLGN IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on CLGN signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds.

It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where CLGN implied volatility sits today versus where it has been. Our scanner ranks CollPlant Biotechnologies Ltd implied volatility against its historical range, surfaces extremes in CLGN IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether CollPlant Biotechnologies Ltd IV is rich or cheap — measure it, then act on it.